ONCO

ONCO

USD

Onconetix Inc. Common Stock

$3.060-0.110 (-3.470%)

Reaalajas hind

Healthcare
Biotehnoloogia
Ameerika Ühendriigid

Hinnagraafik

Loading Chart...

Põhinäitajad

Turunäitajad
Ettevõtte fundamentaalnäitajad
Kauplemisstatistika

Turunäitajad

Avatud

$3.170

Kõrge

$3.170

Madal

$3.060

Maht

0.01M

Ettevõtte fundamentaalnäitajad

Turukapitalisatsioon

4.8M

Tööstusharu

Biotehnoloogia

Riik

United States

Kauplemisstatistika

Keskmine maht

0.14M

Börs

NCM

Valuuta

USD

52 nädala vahemik

Madal $2.45Praegune $3.060Kõrge $251.6

Seotud uudised

PR Newswire

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

Equity InsiderNews Commentary – Major pharmaceutical companies presenting at the European Society for Medical Oncology Congress October 17-21[1] are...

Vaata rohkem
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
GlobeNewswire

Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.

CINCINNATI, OH, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Vaata rohkem
Onconetix Announces Financing Through a $12.9 Million Private Placement of Series D Preferred Stock and Warrants, Termination of Merger Agreement with Ocuvex, Inc. and Settlement of $8.8 Million Debt with Veru, Inc.
GlobeNewswire

Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement

CINCINNATI, OH & FORT LEE, NJ, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc.

Vaata rohkem
Joint Press Release: Onconetix and Ocuvex Announce Mutual Termination of Merger Agreement